Kidney Community Commends Bipartisan Congressional Effort to Support

Private-Public “KidneyX” Partnership to Address Nation’s Growing Kidney

Disease Epidemic

Letter to House Appropriations Committee Leaders Calls for $25 Million in Public Matching Funds
to Support KidneyX to Boost Investment in Kidney Disease Research and Innovation.

Washington, DC, April 01, 2019 --(PR.com)-- Kidney Care Partners (KCP) - the nation's leading kidney
care multi-stakeholder coalition, representing patient advocates, physician organizations, health
professional groups, dialysis providers, researchers and manufacturers - today commended the 58
representatives from both parties who signed a letter this week urging their colleagues on the House
Appropriations Committee to support KidneyX, a public-private partnership to accelerate innovation in
the prevention, diagnosis, and treatment of kidney disease.

The letter, which was led by Representatives Suzan DelBene (D-WA), Brian Babin (R-TX), Terri Sewell
(D-AL) and Larry Bucshon (R-IN), calls for $25 million in public matching funds to support this
partnership in the Fiscal Year 2020 Labor, Health and Human Services, Education, and Related Agencies
appropriations bill. The fund would match a $25 million commitment made by the American Society of
Nephrology (ASN), a KCP member and national physician society whose mission is to fight, prevent,
treat, and cure kidney diseases throughout the world by educating health professionals and scientists,
advancing research and innovation, communicating new knowledge, and advocating for the highest
quality care for patients.

“KCP applauds lawmakers for standing up to support innovative approaches to kidney disease
management,” said Dr. Allen Nissenson, chair of KCP. “Americans living with kidney disease deserve
the best care there is - fully funding KidneyX is an important step towards addressing existing barriers to
innovation in kidney care to ensure patients have access to the latest treatment and technologies.”

KidneyX was first announced in 2018 as a joint public-private partnership between the Department of
Health and Human Services and the American Society of Nephrology to spur the development and
commercialization of innovative technologies and therapeutics in the prevention, diagnosis, and treatment
of kidney diseases. Its first prize competition, Redesign Dialysis, aims to incentivize the development of
next-generation dialysis products and is about to enter Phase 2, in which participants will be asked to
develop and demonstrate prototype dialysis technologies. As a true public-private partnership, the private
sector has already contributed $25 million to fund the program and is committed to matching federal
funding to achieve a total of $250 million over the next five years.

An estimated 30 million American adults are currently living with chronic kidney disease which, if
untreated, can ultimately progress to kidney failure. Furthermore, millions more individuals are at risk of
developing this deadly disease and are not aware of their risks. The kidney care community is dedicated
to providing education and prevention resources to at-risk patients to help slow the rise of kidney failure.

“KCP is very optimistic about that promise of KidneyX, which fills a critical gap in the development of

Page 1/3
PR.com Press Release Distribution Terms of Use
innovative treatments and technologies can make a true and lasting difference for the millions of
individuals living with kidney disease, kidney failure, and kidney transplants today,” concluded Dr.
Nissenson.

About Kidney Care Partners

Kidney Care Partners (KCP) is a coalition of more than 30 organizations, comprised of patient advocates,
dialysis professionals, care providers, researchers, and manufacturers, dedicated to working together to
improve quality of care for individuals with Chronic Kidney Disease (CKD).

Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
Kidney Care Partners
Sarah Ann Rhoades
703-548-0019
Contact via Email
http://www.kidneycarepartners.org/

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/781419

Page 3/3
PR.com Press Release Distribution Terms of Use